JACOBS LEVY EQUITY MANAGEMENT, INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$888,000
+44.4%
33,5000.0%0.01%
+33.3%
Q1 2019$615,000
+47.8%
33,5000.0%0.01%
+28.6%
Q4 2018$416,000
-35.2%
33,5000.0%0.01%
-22.2%
Q3 2018$642,000
+40.8%
33,5000.0%0.01%
+28.6%
Q2 2018$456,000
+88.4%
33,5000.0%0.01%
+75.0%
Q1 2018$242,000
+69.2%
33,500
-13.9%
0.00%
+33.3%
Q4 2017$143,00038,9000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders